Back to search

Article

Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumors

2021-11-17

Abstract excerpt

Although important advances have been made in the knowledge of the molecular mechanisms leading to the development, of head and neck squamous cell carcinoma (HNSCC), only PDL1 is used for the immunotherapy (pemborlizumab) treatment in the first line of metastatic or recurrent disease. There are no other molecular biomarkers currently used in clinical practice. The objective of the study was to identify transcripti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d22de480-7405-555d-8ffd-f0cf58e07e05
DOI
10.1101/2021.11.12.468359
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of a minimal biomarker profile in head-and-neck squamous cell carcinoma tumorsDOI 10.1101/2021.11.12.468359
Select a neighboring publication to make it the new centre.